CIK 0001817241 · <br>Emerging growth company
Artiva Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARTV
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863614316
- Phone
- (858) 267-4467
- Business address
- 5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
- 4 Grant or award Chief Medical Officer acquired 102,000 shares (grant or award)
- 4 Shares withheld for taxes President and CEO gave up 14,600 shares (to pay taxes)
- 4 Planned sale President and CEO sold 3,187 shares at $6.00 ($19,122)
- 144 Insider Sale of Securities
- 4 Grant or award SVP, Research and Development acquired 67,253 shares (grant or award)
- 4 Grant or award Chief Tech Operations Officer acquired 107,156 shares (grant or award)
- 4 Grant or award COO, CLO, Secy, Compliance Off acquired 84,877 shares (grant or award)
- 4 Grant or award President and CEO acquired 869,136 shares (grant or award)
- 8-K Event Executive or director change
- 4 Shares withheld for taxes SVP, Research and Development gave up 1,375 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Tech Operations Officer gave up 1,899 shares (to pay taxes)
- 4 Shares withheld for taxes COO, CLO, Secy, Compliance Off gave up 3,055 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,490 shares (to pay taxes)
- 4 Planned sale President and CEO sold 6,375 shares at $3.38 ($21,522)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale President and CEO sold 25,500 shares at $6.00 ($153,000)
- 144 Insider Sale of Securities
Page 6 of 12 · 234 filings